Trial Profile
A Phase Ⅳ,Open,Multicenter,Single Arm Study to Evaluate the Efficacy of the Combination Conmana With Thalidomide in Patients With NSCLC(Non-Small-Cell-Lung-Cancer)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Icotinib (Primary) ; Thalidomide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 25 May 2016 New trial record